Disruption of this balance, as observed in obesity and T2D, favors YY1-mediated inflammation and metabolic dysfunction, while RKIP downregulation eliminates critical inhibitory checkpoints. Here, YY1 is linked to obesity due to melanocortin 4 receptor deficiency.